Ultrasound is an effective method to identify and prevent interstitial lung disease, one of the most important complications & # 39; systemic sclerosis, said Marwin Gutiérrez Riveros f & # 39; statement.
The head of Musuloskeletriku Diseases Division of the National Institute of Rheumatic Rehabilitation "Luis Guillermo Ibarra Ibarra" of Mexico said that it is also a simple, low cost and easy for patients.
During the XXIII National Meeting of Researchers, Gutiérrez Riveros said pulmonary ultrasound, except that plays a fundamental role as a & # 39; screening tool, accessible and workable, detects this condition in the early stages, even when there is no symptoms.
The interstitial lung disease is a group & # 39; conditions that cause inflammation or scarring of the lungs. "It is the second manifestation in & # 39; patients with systemic sclerosis, but the first cause of death among them", he said.
Gutierrez Riveros explained that systemic sclerosis is characterized by process & # 39; fibrosis, inflammation and degenerative changes in & # 39; several organs, mainly the lungs, kidneys, intestines and brain.
He explained that the most affected are between 35 and 55 people, mostly women; However, in men, although it is less frequent, has a higher rate of & # 39; mortality.
Currently it is said that & # 39; reference method to detect this complication is tomography, whose use is limited in the early stages because of the high radiation, high cost and limited availability & # 39; this device in & # 39; peripheral rural medical centers.
The specialist noted that the National Rehabilitation Institute carried out the study "Diagnostic Value of & # 39; forecasts & # 39; Pulmonary ultrasound in the evaluation of interstitial lung disease in & # 39; systemic sclerosis" which earned first place & # 39; clinical research at the XXIII National Meeting of Researchers.
This research proposes to determine the validity of & # 39; this diagnostic tool in the early detection of & # 39; this condition, a common complication and morbidity and high mortality.
The expert stressed that this work aroused the interest of & # 39; several national and international medical societies, such as the Mexican College of Rheumatology and the European League of Associations of Rheumatology.
It is expected that its use can & # 39; to be standardized and validated in order to make part of studies worldwide.